After a years-long revenue drought, there's a light at the end of the tunnel.
The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead ...
Although it is the leading infectious cause of birth defects, patients and some doctors know little about cytomegalovirus.
In the last six months Pfizer’s stock (NYSE: PFE) has underperformed Merck (NYSE: MRK) and J&J (NYSE: JNJ) primarily due to ...
Centers for Medicare & Medicaid Services on Tuesday named a new group of branded drugs from major pharmaceutical ...
Also: All the news and watercooler chat from Fortune.
The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the ...
Jan 27 (Reuters) - The U.S. Centers for Medicare & Medicaid Services on Tuesday named the 15 new drugs targeted for Medicare ...
The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.
Pfizer Inc. has a rare 3-year tariff exemption and margin defense amid global price parity risks. Click here to read an ...
Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...
6don MSN
SUNY Upstate seeks small army of volunteers for vaccine study against common, deadly infection
Syracuse, NY — Upstate Medical University is looking for 1,000 volunteers — its largest clinical trial to date — to test a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results